Retrospective Study
Copyright ©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 107256
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.107256
Figure 3
Figure 3 Pairwise comparisons among those with differing fibrosis status (total n = 420, no fibrosis group n = 27, liver fibrosis group n = 121, and cirrhosis group n = 272). A: Total bilirubin; B: True conjugated bilirubin; C: Thrombin time; D: Diabetes mellitus treatment program. The Wilcoxon rank-sum test was used for intergroup comparisons of total bilirubin, true conjugated bilirubin and thrombin time, and the χ2 test was used for intergroup comparisons of the diabetes mellitus regimens. TBIL: Total bilirubin; Bc-Tr: True conjugated bilirubin; TT: Thrombin time; DM: Diabetes mellitus. aP < 0.05.